Back to trial details

Intake questionnaire

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Applying to Emory University · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Extensive-stage Small-cell Lung Cancer?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Atlanta for study visits?